Advertisement

The Novel Coronavirus 2019 epidemic and kidneys

Published:March 07, 2020DOI:https://doi.org/10.1016/j.kint.2020.03.001
      Novel Coronavirus disease (COVID-19) is a newly discovered contagious disease caused by severe acute respiratory syndrome (SARS)–coronavirus (CoV)-2 virus, primarily manifesting as an acute respiratory illness with interstitial and alveolar pneumonia, but it can affect multiple organs such as the kidney, heart, digestive tract, blood, and nervous system.

      Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. https://doi.org/10.1001/jama.2020.1585. Accessed March 2, 2020.

      The rapidly spreading outbreak, which first emerged in Wuhan, Hubei Province, China, in December 2019, has since been declared a global pandemic. As of March 16, 2020, 167,511 cases of COVID-19 have been reported worldwide in 151 countries (and a cruise ship), with 6606 deaths.
      World Health Organization
      Coronavirus disease (COVID-2019) situation reports.
      In recent days, the number of cases has risen rapidly in South Korea, Japan, Europe, and the United States.

      Keywords

      To read this article in full you will need to make a payment
      ISN Member Login
      Login with your ISN username and password.
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. https://doi.org/10.1001/jama.2020.1585. Accessed March 2, 2020.

        • World Health Organization
        Coronavirus disease (COVID-2019) situation reports.
        (Available at:)
        • World Health Organization
        Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19).
        (Available at:)
        • World Health Organization
        Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003.
        (Available at:)
        • World Health Organization
        Middle East respiratory syndrome coronavirus (MERS-CoV). November 2019.
        (Available at:)
        http://www.who.int/emergencies/mers-cov/en/
        Date accessed: February 27, 2020
        • Huang C.
        • Wang Y.
        • Li X.
        • et al.
        Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
        The Lancet. 2020; 395: 497-506
        • Center for Disease Control and Prevention
        Frequently asked questions and answers: Coronavirus Disease-2019 (COVID-19) and children.
        (Available at:)
        • Ling L.
        • Taisheng L.
        The National Health Commission of PRC Guideline for diagnosis and treatment of novel coronavirus disease (version 6).
        Natl Med J China. 2020; 100: E001
        • World Health Organization
        Specimen referral for 2019nCoV - operational details of referral laboratories.
        (Available at:)
        • Normile D.
        Singapore claims first use of antibody test to track coronavirus infections.
        (Available at:)
        • Chen N.
        • Zhou M.
        • Dong X.
        • et al.
        Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
        Lancet. 2020; 395: 507-513
      2. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China [e-pub ahead of print]. N Engl J Med. https://doi.org/10.1056/NEJMoa2002032. Accessed March 2, 2020.

      3. Cheng Y, Luo R, Wang K, et al. Kidney impairment is associated with in-hospital death of COVID-19 patients [e-pub ahead of print]. medRxiv 2020.02.18.20023242. https://doi.org/10.1101/2020.02.18.20023242. Accessed March 2, 2020.

        • Li Z.
        • Wu M.
        • Guo J.
        • et al.
        Caution on kidney dysfunctions of 2019-nCoV patients. medRxiv 2020.02.08.20021212.
        Date accessed: March 2, 2020
        • Li W.
        • Moore M.J.
        • Vasilieva N.
        • et al.
        Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.
        Nature. 2003; 426: 450-454
        • Raj V.S.
        • Mou H.
        • Smits S.L.
        • et al.
        Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.
        Nature. 2013; 495: 251-254
        • Peiri J.S.M.
        • Chu C.M.
        • Cheng V.C.C.
        • et al.
        Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.
        Lancet. 2003; 361: 1767-1772
        • Ding Y.
        • He L.
        • Zhang Q.
        • et al.
        Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways.
        J Pathol. 2004; 203: 622-630
      4. The team of Zhong Nanshan responded that the isolation of SARS-CoV-2 from urine remind us to pay more attention to the cleaning of individuals and families.
        Guangzhou Daily. Published February 22, 2020;
        • Expert Team of Chinese Society of Nephrology
        Expert consensus on diagnosis and treatment of 2019 novel coronavirus (2019 - nCoV) infection with acute kidney injury.
        Chin J Nephrol. 2020; 3
        • Gao J.
        • Tian Z.
        • Yang X.
        Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.
        Biosci Trends. 2020; 14: 72-73
        • Chu K.H.
        • Tsang W.K.
        • Tang C.S.
        • et al.
        Acute renal impairment in coronavirus-associated severe acute respiratory syndrome.
        Kidney Int. 2005; 67: 698-705
        • Arabi Y.M.
        • Arifi A.A.
        • Balkhy H.H.
        • et al.
        Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection.
        Ann Intern Med. 2014; 160: 389-397
        • Ghani R.A.
        • Zainudin S.
        • Ctkong N.
        • et al.
        Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration.
        Nephrology (Carlton). 2006; 11: 386-393
        • Chen R.C.
        • Tang X.P.
        • Tan S.Y.
        • et al.
        Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience.
        Chest. 2006; 129: 1441-1452
        • Arabi Y.M.
        • Mandourah Y.
        • Al-Hameed F.
        • et al.
        Corticosteroid therapy for critically ill patients with middle east respiratory syndrome.
        Am J Respir Crit Care Med. 2018; 197: 757-767
        • Stockman L.J.
        • Bellamy R.
        • Garner P.
        SARS: systematic review of treatment effects.
        PLoS Med. 2006; 3: e343
        • Russell C.D.
        • Millar J.E.
        • Baillie J.K.
        Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.
        Lancet. 2020; 395: 473-475
        • Park B.K.
        • Maharjan S.
        • Lee S.I.
        • et al.
        Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex.
        BMB Rep. 2019; 52: 397-402
        • Ma Y.
        • Diao B.
        • Lv X.
        • et al.
        2019 novel coronavirus disease in hemodialysis (HD) patients: report from one HD center in Wuhan, China.
        (Available at:)
        • Expert Team of Chinese Medical Association Nephrology Branch
        Recommendations for prevention and control of novel coronavirus infection in blood purification center (room) from Chinese Medical Association Nephrology Branch.
        Chin J Nephrol. 2020; 36: 82-84
        • Hwang S.-J.
        Guideline for dialysis facilities during COVID-19 outbreak. Taiwan Society of Nephrology.
        (Available at:)
        https://tinyurl.com/yx3zc5up
        Date accessed: March 16, 2020

      Linked Article